학술논문
PSS14 COST-UTILITY ANALYSIS OF RANIBIZUMAB (LUCENTIS®) IN WET-AMD BASED ON REAL-LIFE DATA COLLECTED IN THE HELIOS STUDY AFTER RANIBIZUMAB REIMBURSEMENT IN BELGIUM
Document Type
Abstract
Author
Source
In Value in Health 2011 14(3):A55-A55
Subject
Language
ISSN
1098-3015